Literature DB >> 17481636

Induction of tachyzoite egress from cells infected with the protozoan Neospora caninum by nitro- and bromo-thiazolides, a class of broad-spectrum anti-parasitic drugs.

Marco Esposito1, Shelley Moores, Arunasalam Naguleswaran, Joachim Müller, Andrew Hemphill.   

Abstract

Neospora caninum represents an important pathogen causing stillbirth and abortion in cattle and neuromuscular disease in dogs. Nitazoxanide (NTZ) and its deacetylated metabolite tizoxanide (TIZ) are nitro-thiazolyl-salicylamide drugs with a broad-spectrum anti-parasitic activity in vitro and in vivo. In order to generate compounds potentially applicable in food and breeding animals, the nitro group was removed, and the thiazole-moiety was modified by other functional groups. We had shown earlier that replacement of the nitro-group by a bromo-moiety did not notably affect in vitro efficacy of the drugs against N. caninum. In this study we report on the characterization of two bromo-derivatives, namely Rm4822 and its de-acetylated putative metabolite Rm4847 in relation to the nitro-compounds NTZ and TIZ. IC(50) values for proliferation inhibition were 4.23 and 4.14 microM for NTZ and TIZ, and 14.75 and 13.68 microM for Rm4822 and Rm4847, respectively. Complete inhibition (IC(99)) was achieved at 19.52 and 22.38 microM for NTZ and TIZ, and 18.21 and 17.66 microM for Rm4822 and Rm4847, respectively. However, in order to exert a true parasiticidal effect in vitro, continuous culture of infected fibroblasts in the presence of the bromo-thiazolide Rm4847 was required for a period of 3 days, while the nitro-compound TIZ required 5 days continuous drug exposure. Both thiazolides induced rapid egress of N. caninum tachyzoites from their host cells, and egress was inhibited by the cell membrane permeable Ca(2+)-chelator BAPTA-AM. Host cell entry by N. caninum tachyzoites was inhibited by Rm4847 but not by TIZ. Upon release from their host cells, TIZ-treated parasites remained associated with the fibroblast monolayer, re-invaded neighboring host cells and resumed proliferation in the absence of the drug. In contrast, Rm4847 inhibited host cell invasion and respective treated tachyzoites did not proliferate further. This demonstrated that bromo- and nitro-thiazolides exhibit differential effects against the intracellular protozoan N. caninum and bromo-thiazolides could represent a valuable alternative to the nitro-thiazolyl-salicylamide drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17481636     DOI: 10.1016/j.ijpara.2007.03.007

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  10 in total

1.  Synthesis, biological evaluation, and structure-activity relationships of N-benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), Trypanosomes, and Leishmania.

Authors:  Jozef Stec; Qingqing Huang; Marco Pieroni; Marcel Kaiser; Alina Fomovska; Ernest Mui; William H Witola; Samuel Bettis; Rima McLeod; Reto Brun; Alan P Kozikowski
Journal:  J Med Chem       Date:  2012-03-20       Impact factor: 7.446

2.  In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide.

Authors:  Laura V Ashton; Robert L Callan; Sangeeta Rao; Gabriele A Landolt
Journal:  Vet Med Int       Date:  2010-08-12

3.  Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii.

Authors:  Angela Leepin; Angela Stüdli; Reto Brun; Chad E Stephens; David W Boykin; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2008-03-24       Impact factor: 5.191

4.  Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice.

Authors:  Michelle Schorer; Karim Debache; Fabienne Barna; Thierry Monney; Joachim Müller; David W Boykin; Chad E Stephens; Andrew Hemphill
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-02       Impact factor: 4.077

5.  A quantitative reverse-transcriptase PCR assay for the assessment of drug activities against intracellular Theileria annulata schizonts.

Authors:  Isabel Hostettler; Joachim Müller; Chad E Stephens; Richard Haynes; Andrew Hemphill
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-09-19       Impact factor: 4.077

6.  The tandemly repeated NTPase (NTPDase) from Neospora caninum is a canonical dense granule protein whose RNA expression, protein secretion and phosphorylation coincides with the tachyzoite egress.

Authors:  Iván Pastor-Fernández; Javier Regidor-Cerrillo; Gema Álvarez-García; Virginia Marugán-Hernández; Paula García-Lunar; Andrew Hemphill; Luis M Ortega-Mora
Journal:  Parasit Vectors       Date:  2016-06-21       Impact factor: 3.876

7.  Neospora caninum: Structure and Fate of Multinucleated Complexes Induced by the Bumped Kinase Inhibitor BKI-1294.

Authors:  Pablo Winzer; Nicoleta Anghel; Dennis Imhof; Vreni Balmer; Luis-Miguel Ortega-Mora; Kayode K Ojo; Wesley C Van Voorhis; Joachim Müller; Andrew Hemphill
Journal:  Pathogens       Date:  2020-05-16

8.  Inhibitory action of phenothiazinium dyes against Neospora caninum.

Authors:  Luiz Miguel Pereira; Caroline Martins Mota; Luciana Baroni; Cássia Mariana Bronzon da Costa; Jade Cabestre Venancio Brochi; Mark Wainwright; Tiago Wilson Patriarca Mineo; Gilberto Úbida Leite Braga; Ana Patrícia Yatsuda
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

9.  3D holotomographic monitoring of Ca++ dynamics during ionophore-induced Neospora caninum tachyzoite egress from primary bovine host endothelial cells.

Authors:  C Larrazabal; C Hermosilla; A Taubert; I Conejeros
Journal:  Parasitol Res       Date:  2021-08-13       Impact factor: 2.289

10.  Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research.

Authors:  Megan Neary; Usman Arshad; Lee Tatham; Henry Pertinez; Helen Box; Rajith Kr Rajoli; Anthony Valentijn; Joanne Sharp; Steve P Rannard; Giancarlo A Biagini; Paul Curley; Andrew Owen
Journal:  bioRxiv       Date:  2021-05-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.